Viewing Study NCT00005033


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-31 @ 8:18 PM
Study NCT ID: NCT00005033
Status: COMPLETED
Last Update Posted: 2013-06-21
First Post: 2000-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab in Treating Patients With Recurrent Osteosarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Sarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent osteosarcoma View